(a) whether domestic Pharma industry has sought revision in drug prices by submitting a report on the increase in conversion and packaging cost to National Pharmaceuticals Pricing Authority;
(b) if so, whether drug regulator annually fixes maximum retail price of medicines that contain any one of 74 raw materials that are under price control of the Government;
(c) if so, the details thereof;
(d) whether the Indian Drug Pharmaceutical Association has been asked to submit a report and implement new pricing decision by itself;
(e) if so, whether any final decision has been taken in this regard; and
(f) if so, the details thereof?